Paloma Partners Management CO Eagle Pharmaceuticals, Inc. Transaction History

Paloma Partners Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $274,929 - $309,676	-5,163 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$46.61 - $58.45 $116,851 - $146,534	-2,507 Reduced 32.69%	5,163 $287,000
Q1 2019 May 15, 2019	BUY	$38.66 - $51.82 $296,522 - $397,459	7,670 New	7,670 $387,000
Q1 2018 May 15, 2018	SELL	$52.16 - $66.86 $317,237 - $406,642	-6,082 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$49.6 - $60.87 $128,364 - $157,531	-2,588 Reduced 29.85%	6,082 $325,000
Q3 2017 Nov 14, 2017	BUY	$46.62 - $60.36 $404,195 - $523,321	8,670	8,670 $517,000

8.58M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $8.46M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.